Arrowhead Research reported $30.15M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 19.93M 3.58M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 30.15M 2.37M Sep/2026
Heron Therapeutics USD 8.38M 3.27M Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
Ligand Pharmaceuticals USD 4.1M 5.31M Sep/2026
Merck USD 5.03B 1.2B Sep/2026
Moderna USD 259M 92M Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.24B 15M Sep/2026
Sarepta Therapeutics USD 45.7M 5.28M Sep/2026
TG Therapeutics USD 176.86M 36.83M Sep/2026
Ultragenyx Pharmaceutical USD 45M 6M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026
Xencor USD 6.65M 6M Sep/2026